These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1319250)

  • 1. Rapid reversal of angiotensin converting enzyme inhibition by lisinopril in the perfused rabbit lung.
    Rimar S; Gillis CN
    Pulm Pharmacol; 1992 Jun; 5(2):103-9. PubMed ID: 1319250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of N-[1 (S)-carboxy-(4-OH-3-125I-phenyl)ethyl]-L-Ala-L-Pro, an inhibitor of angiotensin-converting enzyme by rabbit lungs in situ.
    Turrin M; Pitt BR; Ryan JW; Chung AY; Clark MB; Gillis CN
    J Pharmacol Exp Ther; 1986 Jul; 238(1):14-8. PubMed ID: 3014113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apparent kinetics of angiotensin converting enzyme: hydrolysis of [3H]benzoyl-phenylalanyl-alanyl-proline in the isolated perfused lung.
    Ashton JH; Pitt BR; Gillis CN
    J Pharmacol Exp Ther; 1985 Mar; 232(3):602-7. PubMed ID: 2983065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiography.
    Sakaguchi K; Chai SY; Jackson B; Johnston CI; Mendelsohn FA
    Hypertension; 1988 Mar; 11(3):230-8. PubMed ID: 2832327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies.
    Perich RB; Jackson B; Rogerson F; Mendelsohn FA; Paxton D; Johnston CI
    Mol Pharmacol; 1992 Aug; 42(2):286-93. PubMed ID: 1325031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of angiotensin converting enzyme inhibition in tissues following oral lisinopril: studies in the rat using quantitative radioinhibitor binding.
    Jackson B; Cubela R; Sakaguchi K; Johnston CI
    Clin Exp Pharmacol Physiol; 1987 Apr; 14(4):343-7. PubMed ID: 2822313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung MK 351A uptake after hypoxia adaptation and subsequent hyperoxia exposure.
    Jackson RM; Ann HS; Oparil S
    Lung; 1988; 166(4):209-19. PubMed ID: 2849698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma protein binding and endothelial enzyme interactions in the lung.
    Linehan JH; Dawson CA; Bongard RD; Bronikowski TA; Roerig DL
    J Appl Physiol (1985); 1989 Jun; 66(6):2617-28. PubMed ID: 2545661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of rate constants for reactions of pulmonary microvascular angiotensin converting enzyme with an inhibitor and a substrate in vivo.
    Ryan JW; Valido FA; Sequeira MJ; Chung AY; Berryer P; Chen XL; Catravas JD
    J Pharmacol Exp Ther; 1994 Jul; 270(1):260-8. PubMed ID: 8035324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells.
    Thwaites DT; Cavet M; Hirst BH; Simmons NL
    Br J Pharmacol; 1995 Mar; 114(5):981-6. PubMed ID: 7780654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme: zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymes.
    Ehlers MR; Riordan JF
    Biochemistry; 1991 Jul; 30(29):7118-26. PubMed ID: 1649623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme inhibition in plasma and tissues.
    Johnston CI; Cubela R; Sakaguchi K; Jackson B
    Clin Exp Hypertens A; 1987; 9(2-3):307-21. PubMed ID: 3038391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
    Udupa EG; Rao NM
    Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered angiotensin-converting enzyme in lung and extrapulmonary tissues of hypoxia-adapted rats.
    Oparil S; Narkates AJ; Jackson RM; Ann HS
    J Appl Physiol (1985); 1988 Jul; 65(1):218-27. PubMed ID: 2841276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
    Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
    Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lisinopril and ramiprilat protection of the vascular endothelium against free radical-induced functional injury.
    Gillis CN; Chen X; Merker MM
    J Pharmacol Exp Ther; 1992 Jul; 262(1):212-6. PubMed ID: 1320684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of angiotensin I converting enzyme inhibition in the heart.
    Kinoshita A; Urata H; Bumpus FM; Husain A
    Circ Res; 1993 Jul; 73(1):51-60. PubMed ID: 8389676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural constraints of inhibitors for binding at two active sites on somatic angiotensin converting enzyme.
    Perich RB; Jackson B; Johnston CI
    Eur J Pharmacol; 1994 Feb; 266(3):201-11. PubMed ID: 8174603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrolysis of a synthetic angiotensin-converting enzyme substrate in dog lungs.
    Linehan JH; Bronikowski TA; Rickaby DA; Dawson CA
    Am J Physiol; 1989 Dec; 257(6 Pt 2):H2006-16. PubMed ID: 2557772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential uptake of endothelin-1 by the coronary and pulmonary circulations.
    Rimar S; Gillis CN
    J Appl Physiol (1985); 1992 Aug; 73(2):557-62. PubMed ID: 1383183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.